The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Settlement of a major title insurance claim for a 54 acre development project
Served as lead counsel representing the developer of a high profile, 54 acre project in a major title insurance claim arising out of an easement more
Counsel to pipeline company in manufacturing specialized products
Represented pipeline company, as lead counsel, in the design, manufacture and procurement of $5 million worth of specialized products. more
Major trade secret misappropriation and breach of license case for aerospace defense contractor
Lead counsel representing an aerospace defense contractor in a major trade secret misappropriation and breach of license dispute alleging that the more
Acquisition for financial services corporation
Represented a financial services corporation in connection with its acquisition of a leading manufacturer and distributor of truck and trailer more